Gold prices fall from record highs on Gaza ceasefire, but retain $4,000/oz level
Investing.com - Laboratory America (NYSE: LH) reported third quarter EPS of $3.38, $0.05 better than the analyst estimate of $3.33. Revenue for the quarter came in at $3.06B versus the consensus estimate of $2.99B.
Guidance
Laboratory America sees FY 2023 EPS of $13.25-$13.75 versus the analyst consensus of $13.63.
Laboratory America's stock price closed at $197.69. It is down -7.90% in the last 3 months and down -8.60% in the last 12 months.
Laboratory America saw 1 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Laboratory America's stock price’s past reactions to earnings here.
According to InvestingPro, Laboratory America's Financial Health score is "great performance".
Check out Laboratory America's recent earnings performance, and Laboratory America's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar